Come join others currently navigating treatment in our weekly Virtual Support Groups! See times and register here.
We've made it easier for you to connect! Fill out your NEW profile.
Breastcancer.org is hiring! Read the job posting: Virtual Support Group Facilitator and Community Moderator
Diagnosed Young? We'd love your answers to these questions.
Kadcyla Continues to Improve Survival in HER2-Positive Early-Stage Breast Cancer
moderators
Posts: 9,253
Kadcyla Continues to Improve Survival in HER2-Positive Early-Stage Breast Cancer
Dec 17, 2023
More than eight years of follow-up from the KATHERINE trial showed the continued survival benefits of Kadcyla over Herceptin for HER2-positive breast cancer with a high risk of recurrence. Read more…
0
Categories
Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your NEW profile.
Breastcancer.org is hiring! Read the job posting: Virtual Support Group Facilitator and Community Moderator